Larvol Delta - atai-Life-Sciences-Announces-Positive-Initial-Results-from-Beckley-Psytechs-Phase-2a-Open-Label-Study-of-BPL003-Intranasal-5MeODMT-in-Treatment-Resistant-Depression

5-methoxy-dimethyltryptamine dry-powder intranasal (BPL-003) - Beckley Psytech

https://www.globenewswire.com/news-release/2024/03/27/2853041/0/en/atai-Life-Sciences-Announces-Positive-Initial-Results-from-Beckley-Psytech-s-Phase-2a-Open-Label-Study-of-BPL-003-Intranasal-5-MeO-DMT-in-Treatment-Resistant-Depression.html

Mar 27, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next